risks of semaglutide for weight loss 14 Dangerous Taking Ozempic Study identifies benefits, risks linked

I did it for myself and not anyone else

An analysis of real-world integrated pharmacy and medical claims data by leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime), and Magellan Rx Management, (Magellan Rx), a Prime Therapeutics company, shows that 68 percent of individuals who newly started glucagon-like peptide-1 agonist (GLP-1a) drugs for weight loss were no longer taking the drug after one year

However, there were no significant differences in FS and LVEF among the three groups

Approved in 2019 by the FDA for treating hypoactive sexual desire disorder (HSDD) in premenopausal women, its commercially available under the brand Vyleesi